Skip to content
TrialScanner

NCT05483933

Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers

Phase 1CompletedSTTKLead

Registry record

Lead sponsor
Shattuck Labs, Inc.
Conditions
Platinum-resistant Ovarian Cancer; Fallopian Tube Cancer; Epithelial Ovarian Cancer; Ovarian Cancer; Platinum-Resistant Fallopian Tube Carcinoma
Primary completion
Feb 7, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05483933 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.